NASDAQ
5.92USD
-0.04 (-0.67%)
We have scored 68 news catalysts on Regencell Bioscience Holdings Limited (RGC) over the past 12 months. The biggest single-day move next to one of them came Jul 6, 2026, when RGC closed −11.9%: “United Therapeutics Vs. Regencell Bioscience: I Choose Profits Over Promises”. Coverage across the window leans negative (average ticker sentiment −0.73). Most of the impact sits in price momentum and institutional appeal.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
2.9B
P/E
—
EPS
—
Beta
1.43
52W range
4.51-69
Day range
5.83–6.10
Open
5.93
Prev close
5.96
Volume
25K
Avg volume
259K
Dividend
0.00
IPO
2021-07-16
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Regencell Bioscience Holdings Limited — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for RGC: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
